SCHEDULE 13G Filed 2026-08-14 Event — SEC 0001104659-26-097426 →

ADAR1 Capital Management, LLC → Yarrow Bioscience, Inc. YARW

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

13 filings by this filer

12 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 1.00

12,582 shares short · -93.2% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-27	Ashiya Mona	director	Award	15,435	$28.56	$441K
2026-07-27	Zeronda Tyler	director	Award	185,798	$28.56	$5.31M

Other 13D/G Filings on Yarrow Bioscience, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-05	SCHEDULE 13D	ORBIMED ADVISORS LLC	9.97%	266,306	view →
2026-07-29	SCHEDULE 13D/A	AI Biotechnology LLC	6.02%	178,180	view →
2020-04-16	SC	venBio Global Strategic Fund II L.P.	—	—	view →

Other Filings by ADAR1 Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-08-14	SCHEDULE 13G	NextCure, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	Research Alliance Corporation III	—	—	view →
2026-08-14	SCHEDULE 13G	Rein Therapeutics, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	Editas Medicine, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	JATT II Acquisition Corp.	—	—	view →
2026-08-14	SCHEDULE 13G	Amanat Acquisition Corp.	—	—	view →
2026-08-14	SCHEDULE 13G	Boundless Bio, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	Cyclerion Therapeutics, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	Pliant Therapeutics, Inc.	—	—	view →
2026-06-05	SCHEDULE 13G	Rallybio Corporation RLYB	—	—	view →
2026-06-05	SCHEDULE 13G	InMed Pharmaceuticals, Inc. INM	—	—	view →
2025-04-28	SCHEDULE	Keros Therapeutics, Inc. KROS	13.29%	5,390,964	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →